{
    "organizations": [],
    "uuid": "d626012ed61f3d11a74aa44c8db169521781cd59",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-united-health-products-issues-fda/brief-united-health-products-issues-fda-update-idUSASB0C1OQ",
    "ord_in_thread": 0,
    "title": "BRIEF-United Health Products Issues FDA Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - United Health Products Inc:\n* UNITED HEALTH PRODUCTS ISSUES FDA UPDATE * UNITED HEALTH PRODUCTS - CO TO PURSUE PMA CLASS III FILING UNDER FDAâ€˜S CTQ PILOT PROGRAM FOR USE IN INTERNAL SURGICAL PROCEDURES\n* UNITED HEALTH PRODUCTS - DECIDED TO WITHDRAW FROM CLASS II EXTENSION OF USE APPLICATION WITH FDA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-22T21:40:00.000+02:00",
    "crawled": "2018-01-23T18:00:43.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "united",
        "health",
        "product",
        "inc",
        "united",
        "health",
        "product",
        "issue",
        "fda",
        "update",
        "united",
        "health",
        "product",
        "co",
        "pursue",
        "pma",
        "class",
        "iii",
        "filing",
        "fda",
        "ctq",
        "pilot",
        "program",
        "use",
        "internal",
        "surgical",
        "procedure",
        "united",
        "health",
        "product",
        "decided",
        "withdraw",
        "class",
        "ii",
        "extension",
        "use",
        "application",
        "fda",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}